MYC amplification in breast cancer: a chromogenic in situ hybridisation study
AUTOR(ES)
Rodriguez‐Pinilla, S Maria
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1972423Documentos Relacionados
- Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates.
- Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer
- Serum protein changes in breast cancer: a prospective study.
- Delayed presentation in breast cancer: a study in Iranian women
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.